Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Valeant adds Jeffrey Ubben to board

Valeant adds Jeffrey Ubben to board Ubben joins at a crucial time for Valeant as the company tries to take over Allergan, the marketer of Botox and other aesthetic and health products.

Allergan agrees to shareholder meeting on Valeant bid

Allergan agrees to shareholder meeting on Valeant bid The Botox manufacturer has been forced to go ahead with organising the meeting after major shareholder Pershing Square Capital, which is supporting Valeant's bid, managed to convince 31 per cent

Valeant extends Allergan bid deadline to end of 2014

Valeant extends Allergan bid deadline to end of 2014 Valeant had initially given Botox makers Allergan a deadline of August 15, 2014, to make a decision on its $53bn offer, which was proposed in June.

Allergan sues Valeant and Pershing for insider trading

Allergan sues Valeant and Pershing for insider trading The Botox manufacturer filed suit in a Californian court claiming Valeant's hedge fund backer Pershing Square Capital - and its owner Bill Ackman - had fraudulently built up a stake in the ... Last month the Botox manufacturer announced plans to cut 1,

SMC decides Celgene's Imnovid is not cost-effective

SMC decides Celgene's Imnovid is not cost-effective There was also a positive decision on Allergan's Botox (botulinum toxin type A) for use in the management of bladder dysfunctions.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...

Infographics